Skip to main content

Watson can now tell you if you’re at risk for diabetes, thanks to CVS partnership

IBM Watson
Image used with permission by copyright holder
The phrase “jack of all trades” is certainly coming to apply to Watson, IBM’s supercomputer, which already lists among its impressive accomplishments beating Tom Jennings at Jeopardy, developing new culinary masterpieces, and analyzing the tone of emails.  And now Watson can add one more line to its staggering resume.

Thanks to a new partnership with CVS, IBM’s Watson can predict who is at risk for diabetes. IBM plans to “develop custom care management services for CVS customers with chronic illnesses,” which along with diabetes also includes obesity and hypertension. By helping to create a “more connected community,” the national chain of pharmacies hopes that its collaboration with the world’s smartest machine may yield a healthful relationship, one that could potentially save lives.

Recommended Videos

According to IBM’s Thursday press release, the use of “predictive analytics and Watson cognitive computing” will give CVS pharmacists the ability “to transform care management services for patients with chronic disease.” The release continues, “The partnership will enable health care practitioners, including those across the CVS Health enterprise, to use Watson to advance care management beyond programs and services typically available today.”

While it remains to be seen exactly how this partnership will play out, Troyen A. Brennan, chief medical officer for CVS Health, told the Washington Post that “realistic interventions” may be possible within the next couple years. “When you go into a cognitive computing approach like this, you’re not sure what you’re going to turn up,” Brennan noted. “We’re at the point of scientific discovery, not productization.”

IBM is also hopeful about the new horizons this collaboration could open for the company, which has been expanding the functionality of Watson ever since it was first developed around a decade ago. Mike Rhodin, senior vice president, IBM Watson, said in a statement, “The capabilities of the IBM Watson Health Cloud, when coupled with CVS Health’s insights into medication utilization and patient behavior, could prove transformative for the industry. Improving care for people with chronic conditions supports IBM’s commitment to make big plays that advance the health and well-being of the global community.”

So who knows — one day, Watson may be your doctor. And rest assured that it’ll also serve a number of other functions for you as well.

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Aptera’s 3-wheel solar EV hits milestone on way toward 2025 commercialization
Aptera 2e

EV drivers may relish that charging networks are climbing over each other to provide needed juice alongside roads and highways.

But they may relish even more not having to make many recharging stops along the way as their EV soaks up the bountiful energy coming straight from the sun.

Read more
Ford ships new NACS adapters to EV customers
Ford EVs at a Tesla Supercharger station.

Thanks to a Tesla-provided adapter, owners of Ford electric vehicles were among the first non-Tesla drivers to get access to the SuperCharger network in the U.S.

Yet, amid slowing supply from Tesla, Ford is now turning to Lectron, an EV accessories supplier, to provide these North American Charging Standard (NACS) adapters, according to InsideEVs.

Read more
Yamaha offers sales of 60% on e-bikes as it pulls out of U.S. market
Yamaha Pedal Assist ebikes

If you were looking for clues that the post-pandemic e-bike market reshuffle remains in full swing in the U.S., look no further than the latest move by Yamaha.

In a letter to its dealers, the giant Japanese conglomerate announced it will pull out of the e-bike business in the U.S. by the end of the year, according to Electrek.

Read more